News Sentiment

APLM sentiment intelligence

Apollomics Inc. Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 18.52 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.3% over one week, +5.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Apollomics Inc. (APLM) appoints Hung-Hsien Yen to board

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -2.3% Price reacting lower
Trend fit Trend inactive 5.8% over four weeks
Fair value -67.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 42
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 25
Market source 8
dars.gov.et 4
TradingView 4
Sahm 3
GlobeNewswire 2
simplywall.st 2
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 13
Deals and strategy 5
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
Sahm Direct company coverage

Apollomics Regains Full Compliance with Nasdaq Listing Requirements

Apollomics Inc., a biopharmaceutical company, announced it has regained full compliance with Nasdaq's Market Value of Listed Securities (MVLS) requirement. The company had previously received notice of non-compliance but has since maintained the required $35 million MVLS for 10 c

Tone
Positive 77/100
Event
Market update
Published
14 Jul 2026 01:12
Source
Sahm
TradingView Direct company coverage

Apollomics Inc. Class A Actuals & Estimates (BOATS:APLM)

This article provides an overview of Apollomics Inc. (APLM) stock, including its ticker information, analyst forecasts, historical price performance, and financial data. It explains where to find financial reports, its next earnings date, net income, dividend policy, and employee

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 08:10
Source
TradingView
Stock Titan Direct company coverage

Apollomics (APLM) CFO RSU vesting triggers 3,588-share tax withholding

Apollomics Inc. (APLM) CFO Peter Kuan-How Lin reported the vesting of 10,000 Restricted Stock Units (RSUs) on June 15, 2026, which converted into Class A Ordinary Shares. To cover tax obligations related to this vesting, 3,588 shares were disposed of through a tax-withholding mec

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 23:39
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) CEO Hung-Wen Chen gains 5,000 shares as RSUs vest

Apollomics Inc. CEO Hung-Wen Chen acquired 5,000 Class A Ordinary Shares due to the vesting of Restricted Stock Units on June 15, 2026. This transaction was not an open-market trade but an equity compensation event, with shares valued at $0.00 each. Following this, Chen directly

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 02:10
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director receives 500 shares from RSU vesting

Apollomics Inc. director Tsai Hsien-Shu increased his direct equity stake by 500 Class A Ordinary Shares due to the vesting of 500 Restricted Stock Units (RSUs) on June 15, 2026. This transaction is part of a pre-scheduled equity compensation plan, with additional RSUs set to ves

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 02:05
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4] Apollomics Inc. Insider Trading Activity

Apollomics Inc.'s COO, Yi-Kuei Chen, reported insider trading activity involving restricted stock units (RSUs). On June 15, 2026, he exercised 5,000 RSUs, receiving Class A Ordinary Shares, increasing his direct holdings to 15,000 shares. He also has an indirect interest in over

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director vests 500 RSUs into Class A shares

Apollomics Inc. director Hong-Jung Chen converted 500 Restricted Stock Units (RSUs) into 500 Class A Ordinary Shares on June 15, 2026, at an exercise price of $0.00 per share. This transaction increased his direct holdings to 3,620 Class A Ordinary Shares. This vesting event was

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Director at Apollomics (APLM) gains 500 shares from vested RSUs

Apollomics Inc. director Jan Chen-Huan reported a routine equity compensation event where 500 Restricted Stock Units (RSUs) vested into 500 Class A Ordinary Shares on June 15, 2026. Following this transaction, Chen-Huan directly holds 1,500 Class A Ordinary Shares and 500 RSUs. T

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director acquires 500 shares through RSU vesting

Apollomics Inc. director, CHU YI-AN, acquired 500 Class A Ordinary Shares through the vesting and exercise of Restricted Stock Units (RSUs) at a price of $0.00 per share. This transaction, which occurred on June 15, 2026, increased CHU YI-AN's direct holdings to 1,500 Class A Ord

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:10
Source
Stock Titan
Simply Wall Street Direct company coverage

Apollomics (Nasdaq:APLM) - Stock Analysis

Apollomics Inc. (Nasdaq: APLM) is a clinical-stage biopharmaceutical company focused on oncology therapies, with a market capitalization of US$32.9 million. The company faces significant risks including negative shareholder equity, substantial share dilution, and volatile share p

Tone
Negative 19/100
Event
Market update
Published
19 May 2026 14:08
Source
Simply Wall Street
Stock Titan Direct company coverage

Apollomics Inc. (APLM) files F-3/A to register 279,775 Class A shares

Apollomics Inc. has filed an F-3/A amendment to register 279,775 Class A ordinary shares for resale by existing securityholders who acquired them through PIPE subscription agreements. This registration is to satisfy certain registration rights, and Apollomics will not receive any

Tone
Neutral 50/100
Event
Market update
Published
15 May 2026 20:39
Source
Stock Titan
Quiver Quantitative Direct company coverage

APLMW | Apollomics Inc. Warrant Insider Trading

This article provides an overview of Apollomics Inc. Warrant (APLMW) with a focus on potential insider trading activity, institutional holdings, and other financial data. It notes that there is no recent insider trading data or Congress trading data for this ticker. The piece als

Tone
Neutral 50/100
Event
Market update
Published
02 May 2026 20:39
Source
Quiver Quantitative
The Manila Times Direct company coverage

Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress

Apollomics Inc. announced its full-year 2025 financial results, highlighting a strategic turnaround and significant progress in its clinical pipeline. The company is actively advancing vebreltinib, a c-MET inhibitor, with ongoing Phase 2 studies and plans for an IND submission fo

Tone
Positive 71/100
Event
Earnings
Published
30 Apr 2026 21:09
Source
The Manila Times